Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.

Breast cancer research : BCR - 1 Jan 2009

Bild Andrea H, Parker Joel S, Gustafson Adam M, Acharya Chaitanya R, Hoadley Katherine A, Anders Carey, Marcom P Kelly, Carey Lisa A, Potti Anil, Nevins Joseph R, Perou Charles M

Abstract excerpt

INTRODUCTION: Perhaps the major challenge in developing more effective therapeutic strategies for the treatment of breast cancer patients is confronting the heterogeneity of the disease, recognizing that breast cancer is not one disease but multiple disorders with distinct underlying mechanisms....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytotoxins
Share to Databases, Factual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Gene Regulatory Networks

Share to Genetic Heterogeneity

Share to Metabolic Networks and Pathways

Share to Neoplasm Proteins

Share to Oncogenes

Source

Open in PubMed Open full text

Identifiers

PMID: 19638211
DOI: 10.1186/bcr2344
PMCID: PMC2750116

Genes

CTNNB1
MYC
SRC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19638211-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.PMID 19638211Read ↗

A pathway-based classification of human breast cancer.Semantic proximity Read ↗

Introducing Molecular Subtyping of Breast Cancer Into the Clinic?Semantic proximity Read ↗

Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platformsSemantic proximity Read ↗

Breast Cancer Molecular Stratification: From Intrinsic Subtypes to Integrative Clusters.Semantic proximity Read ↗

Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune ActivitySemantic proximity Read ↗

The molecular portraits of breast tumors are conserved across microarray platforms.Semantic proximity Read ↗

Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypesSemantic proximity Read ↗

Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets.Semantic proximity Read ↗

Subtype and pathway specific responses to anticancer compounds in breast cancerSemantic proximity Read ↗

Network-based approach elucidates critical genes in BRCA subtypes and chemotherapy response in Triple Negative Breast CancerSemantic proximity Read ↗

Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like Breast Cancer Based on Functional Differences Using Pathway AnalysisSemantic proximity Read ↗

Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.